๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Endogenous ligands for the epidermal growth factor receptor in human breast tumors do not interfere in an epidermal growth factor receptor radioligand binding assay

โœ Scribed by Clemens B. M. Kienhuis; Paul G. Koenders; Helena Klominska; Theo J. Benraad

Book ID
104873571
Publisher
Springer US
Year
1993
Tongue
English
Weight
435 KB
Volume
27
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Comparison of radioligand assay and immu
Comparison of radioligand assay and immunostaining for epidermal growth factor receptor in human breast cancer
โœ D. J. Hastrich; J. M. Dunn; S. Nicholson; P. Newcomb; Professor J. R. Farndon ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 394 KB ๐Ÿ‘ 2 views

## Abstract Epidermal growth factor (EGF) receptor status is a useful prognostic indicator in women with breast cancer. Lack of standardization and correlation of methodology for the detection of EGF receptor has hampered its further evaluation. EGF receptor status was ascertained by immunohistoche

A simplified immuno-enzymetric assay of
A simplified immuno-enzymetric assay of the epidermal growth factor receptor in breast tumors: Evaluation in 282 cases
โœ M. Grimaux; E. Mady; Y. Remvikos; C. Laine-Bidron; H. Magdelenat ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 720 KB

## Abstract The epidermal growth factor receptor (EGFโ€R) is currently being investigated in human clinical oncology, and particularly in breast cancer, as a potential prognostic factor and a biological target for therapy. As an alternative to the ^125^Iโ€EGF binding assay, we propose a sensitive imm